CBD LIFE SCIENCES INC - CBDL STOCK NEWS

CBD Life Sciences (OTC PINK: CBDL) is preparing to attend the White Label Expo in Las Vegas from May 25-26, 2022. LBC Bioscience Inc., a subsidiary of CBD Life Sciences, aims to showcase their products and establish connections with key distributors. CEO Lisa Nelson noted the significant revenue generated during their previous participation, highlighting the expo's potential for growth. The event will host over 300 exhibitors and offer insights into innovative techniques and technologies in the industry.

CBD Life Sciences (OTC PINK: CBDL) announced the launch of new Delta-9 Gummies through its subsidiary, LBC Bioscience Inc. The gummies feature a 2:1 blend of CBD and Delta-9, offering 200MG of Delta-9 and 400MG of CBD per serving. This product aims to provide a balanced and calming experience. Consumers can expect availability both in-store and on the LBC website soon. The company is also revamping its e-commerce platform for a better shopping experience. CEO Lisa Nelson expressed excitement about the product launch and future updates.

SCOTTSDALE, AZ / ACCESSWIRE / March 10, 2022 / CBD Life Sciences (OTC PINK:CBDL) is gearing up for the ERRL Cup Cannabis Event on March 12-13, 2022, in Mesa, Arizona. This premier event allows CBD Life Sciences to showcase its products to key industry players. CEO Lisa Nelson highlighted the positive revenue impact of participating in such events. CBD Life Sciences emphasizes the extensive benefits of CBD for various health issues. The company offers a range of products, including CBD Bath Bombs and Pain Creams, available through its online store.

CBD Life Sciences (OTC PINK:CBDL) announced the launch of its 300MG Vegan Gummies on Amazon by the end of this week through its subsidiary, LBC Bioscience Inc.. This product aims to expand the company’s presence in the growing eCommerce sector, which has seen significant growth due to global trends.

These gummies are marketed as eco-friendly, toxin-free, and beneficial for inflammation and sleep health. CBD Life Sciences seeks to attract a wider clientele, leveraging Amazon's vast user base.

CBD Life Sciences (OTC PINK: CBDL) announces the upcoming production of HHC products via its subsidiary, LBC Bioscience Inc., set to begin next week. HHC, a stable form of THC, is gaining traction as an alternative cannabinoid, known for benefits such as pain relief and mental clarity. CEO Lisa Nelson highlights the product's potential to aid chronic pain sufferers. The company aims to stay ahead in the competitive cannabinoid space, as it already offers a wide range of CBD products. LBC also promotes its online store and various product offerings.

CBD Life Sciences (OTC PINK:CBDL) announced strategic initiatives in a letter to shareholders. The company plans to acquire new retail locations and vending machines across the United States, citing strong initial revenue from its first vending machine in Tanger Outlets, AZ. CEO Lisa Nelson revealed ongoing efforts to establish a 20,000 sq ft indoor Hemp Facility and hinted at a potential partnership in cryptocurrency mining. Additionally, product expansion in Europe is anticipated by spring 2022. CBD Life Sciences aims to keep shareholders informed as the company grows.

CBD Life Sciences (OTC PINK: CBDL) is expanding its hemp product line into Europe, targeting France, Italy, and Switzerland. CEO Lisa Nelson emphasized the potential revenue growth and customer base expansion this move offers. The company is already stocked with high-quality CBD products including oils, creams, and pet treats. CBD Life Sciences aims to become a global player in the hemp market, leveraging the therapeutic benefits of CBD for various health conditions. The company plans to keep stakeholders updated on its progress.

CBD Life Sciences (OTC PINK:CBDL) has announced plans to install a Bitcoin ATM at one of its retail locations, with future plans for more machines at additional CBD and medical marijuana facilities. The selected machine, Finney3, enhances customer access to cryptocurrencies while promoting increased foot traffic. CEO Lisa Nelson emphasizes the strategic advantage of early adoption of cryptocurrency in retail. The statement also highlights the privacy and security benefits of Bitcoin ATMs compared to online exchanges.

CBD Life Sciences (OTC PINK:CBDL) is launching its first CBD vending machine at the Tanger Outlets Mall in Glendale, Arizona, aiming to provide convenient access to CBD products. This initiative follows the company’s strategy to expand its market presence, with plans for additional machines in Northern Arizona and Las Vegas. The vending machine will offer skincare and pain relief products. Additionally, the company now accepts various cryptocurrencies for online purchases, enhancing customer convenience and engagement.